Detection of drug-induced acute respiratory distress syndrome risk signals in FAERS: a real-world pharmacovigilance study - Takeaways - MDSpire

Detection of drug-induced acute respiratory distress syndrome risk signals in FAERS: a real-world pharmacovigilance study

  • By

  • Yunhan Zhao

  • Feiyang Zhao

  • Haoxiang Hu

  • Jianghai He

  • Yiting Ni

  • Pingping Jin

  • Xiao Wang

  • Zheru Jin

  • Yiren Hu

  • June 11, 2026

  • 0 min

Share

  • 1

    Drug-induced acute respiratory distress syndrome (ARDS) is a serious adverse reaction that is often overlooked in clinical practice.

  • 2

    The study analyzed 15,986 drug-related ARDS reports from the FAERS database, identifying high-risk drug classes and patient demographics.

  • 3

    The most frequently reported drugs associated with ARDS included mycophenolic acid, methotrexate, and amiodarone.

  • 4

    Twenty-two drugs were significantly linked to ARDS risk, with a median onset time of 30 days post-treatment initiation.

  • 5

    Key drug classes with elevated ARDS risk include immunosuppressants, antineoplastic agents, glucocorticoids, and NSAIDs.

Original Source(s)

Detection of drug-induced acute respiratory distress syndrome risk signals in FAERS: a real-world pharmacovigilance study

  • by Yunhan Zhao, Feiyang Zhao, Haoxiang Hu, Jianghai He, Yiting Ni, Pingping Jin, Xiao Wang, Zheru Jin, Yiren Hu

  • June 11, 2026

Related Content

Molecular and spatial specialization of lung interstitial macrophage subsets: beyond chemokines

Staged uniportal video-assisted thoracoscopic bilateral lower lobectomy for bilateral intralobar pulmonary sequestration complicated by Aspergillus infection: a case report

Acupuncture for Neuroinfections?

A recent Perspective offered a speculative mechanistic argument for acupuncture’s potential role as an adjunctive strategy in neuroinfectious diseases.